Results 291 to 300 of about 3,546,540 (364)

Mirikizumab four-year sustained and durable efficacy and safety in ulcerative colitis: Final findings from the LUCENT-3 open-label extension study. [PDF]

open access: yesInflamm Bowel Dis
Sands BE   +11 more
europepmc   +1 more source

BMI-Stratified Risk of Cesarean Delivery Following Labor Induction: A Robson Classification-Based Cohort Study with Predictive Modeling. [PDF]

open access: yesJ Clin Med
Erbey S   +7 more
europepmc   +1 more source

RETRACTION: Mechanism of p27 Upregulation Induced by Downregulation of Cathepsin B and Upar in Glioma

open access: yesMolecular Oncology, EarlyView.
RETRACTION: S. Gopinath, K. Alapati, R. R. Malla, C. S. Gondi, S. Mohanam, D. H. Dinh, and J. S. Rao, “Mechanism of p27 Upregulation Induced by Downregulation of Cathepsin B and Upar in Glioma,” Molecular Oncology 5, no. 5 (2011): 426–437, https://doi.org/10.1016/j.molonc.2011.07.004.
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial.

The Lancet, 2021
BACKGROUND The global prevalence of ulcerative colitis is increasing, and induction and maintenance of remission is a crucial therapeutic goal. We assessed the efficacy and safety of filgotinib, a once-daily, oral Janus kinase 1 preferential inhibitor ...
B. Feagan   +27 more
semanticscholar   +1 more source

THE INDUCTION OF OVULATION

Obstetrical & Gynecological Survey, 1976
A treatment plan utilizing placebo, cyclical steroid therapy, clomiphene citrate, and human pituitary gonadotropin is outlined for the induction of ovulation in carefully selected potentially fertile women. Such a plan minimizes any risk with the potentially hazardous ovulatory stimulants.
J, Evans, L, Townsend
openaire   +2 more sources

Home - About - Disclaimer - Privacy